Sentinel Lymph Node Biopsy in Uterine Cancer: Time for a Modern Approach.

Simple Summary: The sentinel lymph node biopsy technique is widely used in uterine cancers. Some new parameters as ultrastadification or molecular biology have modified our algorithms which are becoming more and more complex. We discuss here the integration of the sentinel node biopsy technique in the global strategy of management of uterine cancers. Since the validation of the sentinel node technique (SLN) for vulvar cancer 20 years ago, this technique has been introduced in the management of operable cervical cancer and endometrial cancer. For cervical cancer a "one fits all" attitude has mainly been presented. However, this approach, consisting of a frozen section during the operation, can be discussed in some stages. We present and discuss the main option for each stage, as well as some secondary possibilities. For endometrial cancer, SLN is now the technique of choice for the nodal staging of low- and intermediate-risk groups. Some discussion exists for the high-risk group. We also discuss the impacts of using preoperatively the molecular classification of endometrial cancer. Patients with POLE or TP53 mutations could have different nodal staging. The story of SLN in uterine cancers is not finished. We propose a comprehensive algorithm of SLN in early cervical and endometrial cancers. However, several ongoing trials will give us important data in the coming years. They could substantially change these propositions. [ABSTRACT FROM AUTHOR]